Introduction
Highly-annotated, well-sourced bio-specimens are essential in elucidating cancer initiation and progression and in validating panels for clinically actionable use. Formalin-fixed, paraffin-embedded (FFPE) tissue archives are most commonly used for oncology research and validation studies. However, accurate mutation detection is often problematic in FFPE tissue since it tends to have highly variable levels of fragmentation that limit the amount of usable DNA templates. In addition, formalin-introduced sequence artifacts and PCR inhibitors further obstruct mutation detection. The lack of consistency between the various protocols for sample handling and extraction of DNA is one of the major obstacles in translating analysis to clinical practice.
This technical note describes the development of a multiplexed panel to determine sample quality and identification (ID) using the MassARRAY® System. This panel performs DNA quality assessment and template copy number enumeration across a broad dynamic range of copies and monitors sample fragment size over a 100-500 bp range, while uniquely identifying the sample using exonic SNPs.